unknown
Stage
1
Investors
About
Epigenica develops multiplexed chromatin profiling technology enabling high-throughput, quantitative analysis of epigenetic marks such as DNA methylation and histone modifications from low input material to support biomedical research and precision medicine.
Explore Epigenica's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.